Literature DB >> 14747516

The cholinergic lesion of Alzheimer's disease: pivotal factor or side show?

Marsel Mesulam1.   

Abstract

A profound loss of cortical cholinergic innervation is a nearly invariant feature of advanced Alzheimer's disease (AD). The temporal course of this lesion and its relationship to other aspects of the disease have not yet been fully clarified. Despite assertions to the contrary, a review of the evidence suggests that a perturbation of cholinergic innervation is likely to be present even in the very early stages of AD. This cholinergic lesion is unlikely to be a major determinant of the clinical symptoms or of the neuropathological lesions. Nonetheless, it almost certainly contributes to the severity of the cognitive and behavioral deficits, especially in the areas of memory and attention. The cholinergic lesion may also influence the progression of the neuropathological process through complex interactions with amyloidogenesis, tau phosphorylation and neuroplasticity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747516     DOI: 10.1101/lm.69204

Source DB:  PubMed          Journal:  Learn Mem        ISSN: 1072-0502            Impact factor:   2.460


  151 in total

1.  Nerve agent exposure elicits site-specific changes in protein phosphorylation in mouse brain.

Authors:  Hongwen Zhu; Jennifer J O'Brien; James P O'Callaghan; Diane B Miller; Qiang Zhang; Minal Rana; Tiffany Tsui; Youyi Peng; John Tomesch; Joseph P Hendrick; Lawrence P Wennogle; Gretchen L Snyder
Journal:  Brain Res       Date:  2010-04-25       Impact factor: 3.252

2.  Concurrent impairments in sleep and memory in amnestic mild cognitive impairment.

Authors:  Carmen E Westerberg; Bryce A Mander; Susan M Florczak; Sandra Weintraub; M-Marsel Mesulam; Phyllis C Zee; Ken A Paller
Journal:  J Int Neuropsychol Soc       Date:  2012-02-03       Impact factor: 2.892

3.  Disruption of odour quality coding in piriform cortex mediates olfactory deficits in Alzheimer's disease.

Authors:  Wen Li; James D Howard; Jay A Gottfried
Journal:  Brain       Date:  2010-08-19       Impact factor: 13.501

4.  Carbachol-induced long-term synaptic depression is enhanced during senescence at hippocampal CA3-CA1 synapses.

Authors:  Ashok Kumar
Journal:  J Neurophysiol       Date:  2010-05-26       Impact factor: 2.714

5.  Effects of cholinesterase inhibitor on brain activation in Alzheimer's patients measured with functional near-infrared spectroscopy.

Authors:  Florian G Metzger; Ann-Christine Ehlis; Florian B Haeussinger; Andreas J Fallgatter; Katja Hagen
Journal:  Psychopharmacology (Berl)       Date:  2015-09-11       Impact factor: 4.530

6.  Age-related memory impairments due to reduced blood glucose responses to epinephrine.

Authors:  Ken A Morris; Qing Chang; Eric G Mohler; Paul E Gold
Journal:  Neurobiol Aging       Date:  2009-01-28       Impact factor: 4.673

7.  Ubiquitin C-terminal hydrolase L1 interacts with choline transporter in cholinergic cells.

Authors:  Sigurd Hartnett; Fan Zhang; Allison Abitz; Yifan Li
Journal:  Neurosci Lett       Date:  2014-02-11       Impact factor: 3.046

8.  Effect of cholinergic signaling on neuronal cell bioenergetics.

Authors:  Jianghua Lu; Lezi E; Nairita Roy; Lewis Hutfles; Eva Selfridge; Eric Funk; Jeffrey M Burns; Russell H Swerdlow
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

9.  Sources of cortical rhythms in adults during physiological aging: a multicentric EEG study.

Authors:  Claudio Babiloni; Giuliano Binetti; Andrea Cassarino; Gloria Dal Forno; Claudio Del Percio; Florinda Ferreri; Raffaele Ferri; Giovanni Frisoni; Silvana Galderisi; Koichi Hirata; Bartolo Lanuzza; Carlo Miniussi; Armida Mucci; Flavio Nobili; Guido Rodriguez; Gian Luca Romani; Paolo M Rossini
Journal:  Hum Brain Mapp       Date:  2006-02       Impact factor: 5.038

10.  Brain atrophy in primary progressive aphasia involves the cholinergic basal forebrain and Ayala's nucleus.

Authors:  Stefan J Teipel; Wilhelm Flatz; Nibal Ackl; Michel Grothe; Ingo Kilimann; Arun L W Bokde; Lea Grinberg; Edson Amaro; Vanja Kljajevic; Eduardo Alho; Christina Knels; Anne Ebert; Helmut Heinsen; Adrian Danek
Journal:  Psychiatry Res       Date:  2013-12-06       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.